Ertapenem versus cefotetan prophylaxis in elective colorectal surgery

New England Journal of Medicine

Volumn 355, Issue 25, 2006, Pages 2640-2651

  Itani, Kamal M F ^a,e   Wilson, Samuel E ^b   Awad, Samir S ^c   Jensen, Erin H ^d   Finn, Tyler S ^d   Abramson, Murray A ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; ERTAPENEM;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ADULT; ANASTOMOSIS LEAKAGE; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; FEVER; HUMAN; HYPERTENSION; ILEUS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OLIGURIA; OUTCOME ASSESSMENT; PARESTHESIA; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTHROMBIN TIME; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SINGLE DRUG DOSE; SMALL INTESTINE OBSTRUCTION; SURGICAL INFECTION; TACHYCARDIA; TREATMENT FAILURE; URINARY TRACT INFECTION; VOMITING; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BETA-LACTAMS; CEFOTETAN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLORECTAL SURGERY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL WOUND INFECTION; TREATMENT FAILURE;

EID: 33845693164     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa054408     Document Type: Article

References (28)

1. Shah PM, Isaacs RD. Ertapenem, the first of a new group of carbapenems. J Antimicrob Chemother 2003;52:538-42.
2. Yellin AE, Hassett JM, Fernandez A, et al. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents 2002;20:165-73.
3. Solomkin JS, Yellin AE, Rotstein OD, et al. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg 2003;237:235-45.
4. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999;27:97-132.
5. Gorbach SL. Antimicrobial prophylaxis for appendectomy and colorectal surgery. Rev Infect Dis 1991;13:Suppl 10:S815-S820.
6. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005;189:395-404.
7. Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174-82.
8. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 1993;128:79-88. [Erratum, Arch Surg 1993;128:410.]
9. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clin Infect Dis 1994;18:422-7.
10. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999;56:1839-88.
11. Discontinued drugs. Rockville, MD: Center for Drug Evaluation and Research, 2006. (Accessed November 21, 2006, at http://www.fda.gov/cder/drug/ shortages/#disc.)
12. Tang R, Chen HH, Wang YL, et al. Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg 2001;234:181-9.
13. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidance for industry - E6 good clinical practice: consolidated guidance. April 1996. (Accessed November 21, 2006, at http://www.fda.gov/cder/guidance/959fnl.pdf.)
14. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992;20:271-4.
15. M2-A7, methods for disk diffusion antimicrobial susceptibility testing of aerobic bacteria - approved standard. 7th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
16. M7-A5, methods for dilution antimicrobial susceptibility testing of aerobic bacteria - approved standard. 7th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
17. M11-A5, methods for dilution antimicrobial susceptibility testing of bacteria that grow anaerobically - approved standard. 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
18. Hershman MJ, Swift RI, Reilly DT, et al. Prospective comparative study of cefotetan with piperacillin for prophylaxis against infection in elective colorectal surgery. J R Coll Surg Edinb 1990;35:29-32.
19. Milsom JW, Smith DL, Corman ML, Howerton RA, Yellin AE, Luke DR. Double-blind comparison of single dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Am J Surg 1998;176:Suppl 6A:46S-52S.
20. Arnaud JP, Bellissant E, Boissel P, et al. Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. J Hosp Infect 1992;22:Suppl A:23-32.
21. Bellantone R, Pacelli F, Sofo L, et al. Systemic perioperative prophylaxis in elective oncological colorectal surgery: cefotetan versus clindamicin plus aztreonam. Drugs Exp Clin Res 1988;14:763-6.
22. Periti P, Mazzei T, Tonelli F. Single dose cefotetan vs. multiple-dose cefoxitin - antimicrobial prophylaxis in colorectal surgery: results of a prospective multicenter, randomized study. Dis Colon Rectum 1989;32:121-7.
23. Periti P, Tonelli F, Mazzel T, Ficari F. Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. J Chemother 1993;5:37-42.
24. Skipper D, Karran SJ. A randomized prospective study to compare cefotetan with cefuroxime plus metronidazole as prophylaxis in elective colorectal surgery. J Hosp Infect 1992;21:73-7.
25. Morton AL, Taylor EW, Lindsay G, Wells GR. A multicenter study to compare cefotetan alone with cefotetan and metronidazole as prophylaxis against infection in elective colorectal operations. Surg Gynecol Obstet 1989;169:41-5.
26. Jagelman DG, Fabian TC, Nichols RL, Stone HH, Wilson SE, Zellner SR. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery. Am J Surg 1988;155:71-6.
27. Smith RL, Bohl JK, McElearney ST, et al. Wound infection after elective colorectal resection. Ann Surg 2004;239:599-607.
28. Miransky J, Ruo L, Nicoletta S, et al. Impact of a surgeon-trained observer on accuracy of colorectal surgical site infection rates. Dis Colon Rectum 2001;44:1100-5.